End-of-day quote
Egyptian Exchange
06:00:00 2024-04-29 pm EDT
|
5-day change
|
1st Jan Change
|
60
EGP
|
-10.18%
|
|
-30.07%
|
+0.77%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
860.1
|
860.8
|
952.5
|
2,337
|
4,333
|
4,730
|
-
|
-
|
Enterprise Value (EV)
1 |
1,695
|
1,695
|
1,431
|
2,818
|
5,463
|
6,463
|
6,415
|
4,730
|
P/E ratio
|
4.23
x
|
6.8
x
|
-
|
3.41
x
|
7.15
x
|
5.23
x
|
5.08
x
|
-
|
Yield
|
6.35%
|
2.03%
|
-
|
-
|
-
|
5.69%
|
5.85%
|
-
|
Capitalization / Revenue
|
0.49
x
|
0.6
x
|
-
|
0.64
x
|
0.76
x
|
0.75
x
|
0.72
x
|
-
|
EV / Revenue
|
0.97
x
|
1.19
x
|
-
|
0.77
x
|
0.96
x
|
1.02
x
|
0.97
x
|
-
|
EV / EBITDA
|
3.69
x
|
5.1
x
|
-
|
2.9
x
|
4.35
x
|
4.4
x
|
4.3
x
|
-
|
EV / FCF
|
-11.7
x
|
18.7
x
|
-
|
-
|
-40.2
x
|
14.3
x
|
11.2
x
|
6.37
x
|
FCF Yield
|
-8.54%
|
5.35%
|
-
|
-
|
-2.49%
|
6.99%
|
8.92%
|
15.7%
|
Price to Book
|
0.69
x
|
0.65
x
|
-
|
1.1
x
|
1.84
x
|
1.38
x
|
1.16
x
|
-
|
Nbr of stocks (in thousands)
|
72,767
|
72,767
|
72,767
|
72,767
|
72,767
|
72,767
|
-
|
-
|
Reference price
2 |
11.82
|
11.83
|
13.09
|
32.11
|
59.54
|
65.00
|
65.00
|
65.00
|
Announcement Date
|
2/27/20
|
2/25/21
|
2/28/22
|
3/1/23
|
3/3/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
1,750
|
1,424
|
-
|
3,674
|
5,710
|
6,317
|
6,581
|
-
|
EBITDA
1 |
459.7
|
332.1
|
-
|
972.9
|
1,256
|
1,469
|
1,493
|
-
|
EBIT
1 |
406.5
|
283.4
|
-
|
895.5
|
1,156
|
1,355
|
1,367
|
-
|
Operating Margin
|
23.22%
|
19.9%
|
-
|
24.37%
|
20.25%
|
21.45%
|
20.77%
|
-
|
Earnings before Tax (EBT)
1 |
269.7
|
173.8
|
-
|
-
|
918.2
|
1,167
|
1,201
|
-
|
Net income
1 |
203.6
|
126.9
|
-
|
755.4
|
699.9
|
905
|
931
|
-
|
Net margin
|
11.63%
|
8.92%
|
-
|
20.56%
|
12.26%
|
14.33%
|
14.15%
|
-
|
EPS
2 |
2.798
|
1.740
|
-
|
9.420
|
8.330
|
12.43
|
12.79
|
-
|
Free Cash Flow
1 |
-144.8
|
90.72
|
-
|
-
|
-135.9
|
452
|
572
|
742
|
FCF margin
|
-8.27%
|
6.37%
|
-
|
-
|
-2.38%
|
7.16%
|
8.69%
|
-
|
FCF Conversion (EBITDA)
|
-
|
27.32%
|
-
|
-
|
-
|
30.77%
|
38.31%
|
-
|
FCF Conversion (Net income)
|
-
|
71.46%
|
-
|
-
|
-
|
49.94%
|
61.44%
|
-
|
Dividend per Share
2 |
0.7500
|
0.2400
|
-
|
-
|
-
|
3.700
|
3.800
|
-
|
Announcement Date
|
2/27/20
|
2/25/21
|
2/28/22
|
3/1/23
|
3/3/24
|
-
|
-
|
-
|
Fiscal Period: December |
2023 S1
|
---|
Net sales
|
-
|
EBITDA
|
-
|
EBIT
|
-
|
Operating Margin
|
-
|
Earnings before Tax (EBT)
|
-
|
Net income
1 |
435.2
|
Net margin
|
-
|
EPS
2 |
5.530
|
Dividend per Share
|
-
|
Announcement Date
|
8/28/23
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
835
|
834
|
478
|
481
|
1,131
|
1,733
|
1,685
|
-
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
1.816
x
|
2.51
x
|
-
|
0.4947
x
|
0.9002
x
|
1.18
x
|
1.129
x
|
-
|
Free Cash Flow
1 |
-145
|
90.7
|
-
|
-
|
-136
|
452
|
572
|
742
|
ROE (net income / shareholders' equity)
|
17.5%
|
9.88%
|
21.1%
|
41%
|
31.3%
|
29.1%
|
24.8%
|
-
|
ROA (Net income/ Total Assets)
|
8.63%
|
4.79%
|
-
|
20.3%
|
13.8%
|
14.4%
|
13.5%
|
-
|
Assets
1 |
2,357
|
2,651
|
-
|
3,730
|
5,069
|
6,285
|
6,896
|
-
|
Book Value Per Share
2 |
17.20
|
18.10
|
-
|
29.10
|
32.30
|
47.10
|
56.00
|
-
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
1 |
82.7
|
58.3
|
-
|
322
|
504
|
316
|
329
|
274
|
Capex / Sales
|
4.72%
|
4.09%
|
-
|
8.77%
|
8.83%
|
5%
|
5%
|
-
|
Announcement Date
|
2/27/20
|
2/25/21
|
2/28/22
|
3/1/23
|
3/3/24
|
-
|
-
|
-
|
Average target price
47
EGP Spread / Average Target -27.69% Consensus |
1st Jan change
|
Capi.
|
---|
| +0.77% | 94.08M | | +18.91% | 37.68B | | -4.00% | 7.21B | | +3.64% | 6.64B | | -5.50% | 5.86B | | -3.05% | 5.69B | | -11.31% | 5.54B | | +29.81% | 5.13B | | -15.16% | 4.56B | | +7.72% | 3.87B |
Other Agricultural Chemicals
|